Comparison and optimal use of fixed combinations in the management of COPD

References

• AalbersRBackerVKavaTT2004Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthmaCurr Med Res Opin202254015006018
   PubMed Web of Science ®Google Scholar
• BalzanoGBattiloroRBiraghiM2000Effectiveness and acceptability of a domiciliary multidrug inhalation treatment in elderly patients with chronic airflow obstruction: metered dose inhaler versus jet nebulizerJ Aerosol Med13253310947321
   PubMedGoogle Scholar
• BarnesNCQiuYSPavordID2006Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung diseaseAm J Respir Crit Care Med1737364316424444
   PubMed Web of Science ®Google Scholar
• BourbeauJJulienMMaltaisF2003Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management interventionArch Intern Med1635859112622605
   PubMed Web of Science ®Google Scholar
• BroddeOEHoweUEgerszegiS1988Effect of prednisolone and ketotifen on beta 2-adrenoceptors in asthmatic patients receiving beta 2-bronchodilatorsEur J Clin Pharmacol34145502898369
   PubMed Web of Science ®Google Scholar
• [BTS] British Thoracic Society1997BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTSThorax52S128
   Web of Science ®Google Scholar
• BurnellPKSmallTDoigS2001Ex-vivo product performance of Diskus and Turbuhaler inhalers using inhalation profiles from patients with severe chronic obstructive pulmonary diseaseRespir Med953243011392571
   PubMed Web of Science ®Google Scholar
• CalverleyPPauwelsRJonesP2006The severity of airway obstruction as a determinant of treatment response in COPDInt J COPD120918
   Google Scholar
• CalverleyPPauwelsRVestboJ2003aCombined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trialLancet3614495612583942
   PubMed Web of Science ®Google Scholar
• CalverleyPM2004Effect of corticosteroids on exacerbations of asthma and chronic obstructive pulmonary diseaseProc Am Thorac Soc1161616113429
   PubMedGoogle Scholar
• CalverleyPMBoonsawatWCsekeZ2003bMaintenance therapy with budesonide and formoterol in chronic obstructive pulmonary diseaseEur Respir J229121914680078
   PubMed Web of Science ®Google Scholar
• CampbellMElirazAJohanssonG2005Formoterol for maintenance and as-needed treatment of chronic obstructive pulmonary diseaseRespir Med9915112016199148
   PubMed Web of Science ®Google Scholar
• CazzolaMSantusPDi MarcoMF2003Bronchodilator effect of an inhaled combination therapy with salmeterol + fluticasone and formoterol + budesonide in patients with COPDRespir Med97453712735659
   PubMed Web of Science ®Google Scholar
• CelliBRMacNeeW2004Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEur Respir J239324615219010
   PubMed Web of Science ®Google Scholar
• Dal NegroRWPomariCTognellaS2003Salmeterol & fluticasone 50 microg/250 microg bid in combination provides a better long-term control than salmeterol 50 microg bid alone and placebo in COPD patients already treated with theophyllinePulm Pharmacol Ther16241612850128
   PubMed Web of Science ®Google Scholar
• GizyckiMJHattotuwaKLBarnesN2002Effects of fluticasone propionate on inflammatory cells in COPD: an ultrastructural examination of endobronchial biopsy tissueThorax5779980312200525
   PubMed Web of Science ®Google Scholar
• [GSK] GlaxoSmithKline2006Press release [online]. Accessed 30 June 2006. URL: http://www.gsk.com
   Google Scholar
• [GOLD] Global Inititive for Chronic Obstructive Lung Disease2006Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: executive summary (updated 2006) [online]. Accessed 1 June 2007. URL: http://www.goldcopd.org
   Google Scholar
• GosmanMMELapperreTSSnoeck-StrobandJB2006Effect of 6 month therapy with inhaled fluticasone propionate (FP) with or without salmeterol (S) on bronchial inflammation in COPD [abstract]ATS conferenceA111
   Google Scholar
• HananiaNADarkenPHorstmanD2003The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPDChest12483484312970006
   PubMed Web of Science ®Google Scholar
• HaqueRATorregoAEssilfie-QuayeS2006Effects of salmeterol and fluticasone on glucocorticoid receptor translocation in sputum macrophages and peripheral blood mononuclear cells from patients with chronic obstructive pulmonary disease [abstract]ATS conferenceA848
   Google Scholar
• HattotuwaKLGizyckiMJAnsariTW2002The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy studyAm J Respir Crit Care Med1651592612070058
   PubMed Web of Science ®Google Scholar
• HaughneyJBarnesGPartridgeM2004The Living & Breathing Study: a study of patients’ views of asthma and its treatmentPrim Care Respir J13283516701634
   PubMedGoogle Scholar
• HaynesRBYaoXDeganiA2005Interventions to enhance medication adherenceCochrane Database Syst Rev4CD00001116235271
   PubMedGoogle Scholar
• HutchinsonAFThompsonMABrandCA2006Patient self-management training and a nurse-led rapid assessment service in the community decreases severity of exacerbations and readmission rates in the Melbourne Longitudinal COPD Cohort (MLCC) [abstract]ATS conferenceA811
   Google Scholar
• JefferyPKVengePGizyckiMJ2002Effects of salmeterol on mucosal inflammation in asthma: a placebo-controlled studyEur Respir J2013788512503692
   PubMed Web of Science ®Google Scholar
• LipworthBJFardonTC2004Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalersJ Allergy Clin Immunol113178914713929
   PubMed Web of Science ®Google Scholar
• MahlerDAWirePHorstmanD2002Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med16610849112379552
   PubMed Web of Science ®Google Scholar
• MakJCNishikawaMBarnesPJ1995bGlucocorticosteroids increase beta 2-adrenergic receptor transcription in human lungAm J Physiol268L4167840227
   PubMed Web of Science ®Google Scholar
• MakJCNishikawaMShirasakiH1995aProtective effects of a glucocorticoid on downregulation of pulmonary beta 2-adrenergic receptors in vivoJ Clin Invest96991067615841
   PubMed Web of Science ®Google Scholar
• MapelDWHurleyJSRoblinD2006aSurvival of COPD patients using inhaled corticosteroids and long-acting beta agonistsRespir Med10059560916199151
   PubMed Web of Science ®Google Scholar
• MapelDWNelsonLSLydickE2006bSurvival of COPD patients using the Advair (R) diskus, inhaled corticosteroids and salmeterol individually, inhaled corticosteroids alone, or short acting bronchodilators alone [abstract]ATS conferenceA110
   Google Scholar
• MetcalfeSMoodieP2004Seretide meta-analysis missed important features and overstates any advantages over concurrent LABA/ICS devicesJ Allergy Clin Immunol113568915007365
   PubMed Web of Science ®Google Scholar
• MonninkhofEvan der ValkPJvan der PalenJ2003Self-management education for patients with chronic obstructive pulmonary disease: a systematic reviewThorax58394812728158
   PubMed Web of Science ®Google Scholar
• NanniniLCatesCJLassersonTJ2004Combined corticosteroid and long acting beta-agonist in one inhaler for chronic obstructive pulmonary diseaseCochrane Database Syst Rev3CD00379415266502
   PubMedGoogle Scholar
• NelsonHSChapmanKRPykeSD2003Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalersJ Allergy Clin Immunol112293612847476
   PubMed Web of Science ®Google Scholar
• [NICE] National Institute for Clinical Excellence2004Chronic obstructive pulmonary disease: national clinical guideline for management of chronic obstructive pulmonary disease in adults in primary and secudary careThorax59Suppl I
   Google Scholar
• O’ByrnePMBisgaardHGodardPP2005Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthmaAm J Respir Crit Care Med1711293615502112
   PubMed Web of Science ®Google Scholar
• SeemungalTADonaldsonGCBhowmikA2000Time course and recovery of exacerbations in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med16116081310806163
   PubMed Web of Science ®Google Scholar
• SeemungalTADonaldsonGCPaulEA1998Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1571418229603117
   PubMed Web of Science ®Google Scholar
• SinghD2006The benefits of combined treatment with corticosteroids and long-acting beta agonistsInt J COPD12078
   Google Scholar
• Soler-CatalunaJJMartinez-GarciaMARomanSP2005Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary diseaseThorax609253116055622
   PubMed Web of Science ®Google Scholar
• SorianoJBKiriVAPrideNB2003Inhaled corticosteroids with/without long-acting beta-agonists reduce the risk of rehospitalization and death in COPD patientsAm J Respir Med2677414720023
   PubMedGoogle Scholar
• StoloffSWStempelDAMeyerJ2004Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapiesJ Allergy Clin Immunol1132455114767437
   PubMed Web of Science ®Google Scholar
• SuissaS2006Statistical treatment of exacerbations in therapeutic trials of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med173842616439716
   PubMed Web of Science ®Google Scholar
• SzafranskiWCukierARamirezA2003Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary diseaseEur Respir J21748112570112
   PubMed Web of Science ®Google Scholar
• ToelleBGRamFS2004Written individualised management plans for asthma in children and adultsCochrane Database Syst Rev2CD00217115106169
   PubMedGoogle Scholar
• van der PalenJKleinJJSchildkampAM1998Comparison of a new multidose powder inhaler (Diskus/Accuhaler) and the Turbuhaler regarding preference and ease of useJ Asthma35147529576140
   PubMed Web of Science ®Google Scholar
• van der WoudeHJBoorsmaMBergqvistPB2004Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstrictionPulm Pharmacol Ther17899515123230
   PubMed Web of Science ®Google Scholar
• van GrunsvenPMvan SchayckCPvan DeuverenM2000Compliance during long-term treatment with fluticasone propionate in subjects with early signs of asthma or chronic obstructive pulmonary disease (COPD): results of the Detection, Intervention, and Monitoring Program of COPD and Asthma (DIMCA) StudyJ Asthma372253410831147
   PubMed Web of Science ®Google Scholar
• VestboJ2004The TORCH (towards a revolution in COPD health) survival study protocolEur Respir J242061015332386
   PubMed Web of Science ®Google Scholar
• WallinASandstromTSoderbergM1999The effects of regular inhaled formoterol, budesonide, and placebo on mucosal inflammation and clinical indices in mild asthmaAm J Respir Crit Care Med15979869872822
   PubMed Web of Science ®Google Scholar
• WedzichaJADonaldsonGC2003Exacerbations of chronic obstructive pulmonary diseaseRespir Care4812041314651761
   PubMedGoogle Scholar
• WoutersEFPostmaDSFokkensB2005Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trialThorax60480715923248
   PubMed Web of Science ®Google Scholar
• YamauchiYChristodoulopoulosPMaltaisF2006The effect of salmeterol/fluticasone combination on airway inflammation in COPD compared to fluticasone [abstract]ATS conferenceA113
   Google Scholar
• ZetterstromOBuhlRMellemH2001Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide aloneEur Respir J18262811529282
   PubMed Web of Science ®Google Scholar